Simpson, Rupert F. G.
Dankiewicz, Josef
Karamasis, Grigoris V.
Pelosi, Paolo
Haenggi, Matthias
Young, Paul J.
Jakobsen, Janus Christian
Bannard-Smith, Jonathan
Wendel-Garcia, Pedro D.
Taccone, Fabio Silvio
Nordberg, Per
Wise, Matt P.
Grejs, Anders M.
Lilja, Gisela
Olsen, Roy Bjørkholt
Cariou, Alain
Lascarrou, Jean Baptiste
Saxena, Manoj
Hovdenes, Jan
Thomas, Matthew
Friberg, Hans
Davies, John R.
Nielsen, Niklas
Keeble, Thomas R.
Article History
Received: 5 September 2022
Accepted: 24 October 2022
First Online: 15 November 2022
Declarations
:
: This is a sub-study from the original TTM-2 trial. The protocol for this trial was approved by the ethics committees in each participating country. Written informed consent was waived, deferred, or obtained from a legal surrogate, depending on the circumstances, and was obtained from each patient who regained mental capacity.
: Dr Young reports receiving lecture fees from Bard Medical. Dr Wise receives honoraria from Gilead and Fisher & Paykel for educational lectures. Dr Keeble reports receiving lecture fees from BD, and a research grant from Zoll. Dr Cariou received fees from Bard Medical. Professor Taccone receives lecture fees from BD and ZOLL. Professor Friberg is a scientific advisor TEQCool (Lund, Sweden).